Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

There is a significant need for better-validated quality of life tools in dermatology.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

This model can replace animal testing for quick, cost-effective skin toxicity tests.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

RXR agonists may promote hair growth in humans.

A method was developed to grow millions of hair cells from a single hair for research and storage.

Hair follicles and sweat glands show different keratin staining patterns.

Some plants like spinach, broccoli, and matcha may boost the effectiveness of the hair growth drug minoxidil.

Bimatoprost can help treat hair loss.

Oral Apremilast effectively treats alopecia areata in most patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.